His-based intelligent therapeutic drug monitoring whole process management system and its method

Abstract

The invention discloses an HIS based intelligent therapeutic drug monitoring whole process management system and a method thereof. The therapeutic drug monitoring whole process management system comprises a management control system, an HIS system, a TDM knowledge database, a prompt information base and a nursing workstation, wherein the management control system comprises a control module as well as an extraction module, a query module and a storage writing module connected with the control module, the output end of the HIS system is connected with the input end of the extraction module, the query module is connected with the TDM knowledge database and the prompt information base, the storage writing module is connected with the TDM knowledge database and the prompt information base, and the nursing workstation is connected with the control module. The system can effectively avoid the repeated detection of drug related genes, ensure the qualified rate of plasma concentration specimens, improve the working efficiency of the staff, and reduce the waste of medical resources fundamentally.

Description

technical field [0001] The invention relates to the technical field of an intelligent therapeutic drug monitoring (TDM) whole-process management system and method, in particular to an HIS-based intelligent therapeutic drug monitoring full-process management system and a method thereof. Background technique [0002] At present, the therapeutic drug monitoring departments of various hospitals widely use the LIS (Southern Medical Laboratory) system to issue reports on drug-related testing items, and there is no intelligent management system suitable for their own use. Qualified samples are the prerequisite for therapeutic drug monitoring to play a role. In the actual work process, pharmacists cannot track and intervene in various links before sample testing in a timely and effective manner, resulting in repeated drug-related gene testing and wrong sample collection time. Waste of medical resources such as blood drug concentration monitoring. For example, in blood drug concentr...

AI Technical Summary

Problems solved by technology

Qualified samples are the prerequisite for therapeutic drug monitoring to play a role. In the actual work process, pharmacists cannot track and intervene in various links before sample testing in a timely and effective manner, resulting in repeated drug-related gene testing and wrong sample collection time. Waste of medical resources such as blood drug concentration monitoring

For example, in blood drug concentration monitoring, the test results at different monitoring time points have significant differences. In clinical practice, the actual collection time of blood drug concentration samples does not meet the required monitoring time points, resulting in poor clinical guiding significance of the monitoring results.

In response to the above problems and clinical feedback, doctors have noted the correct blood collection time in the doctor's order. In fact, clinical nurses have to collect blood for a large number of patients in the morning to test various indicators, and they cannot completely collect blood at the correct time. Training and communication are combined. can't fundamentally solve the problem

Images